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correlation with high sensitivity C-reactive protein. 
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ABSTRACT 
Background: Rheumatic fever (RF) and rheumatic heart disease (RHD) are leading causes of 
cardiovascular mortality and morbidity in developing countries.  
Objectives: To describe the clinical and echocardiographic features of children with RF and RHD and 
compare these features with their serum C-reactive protein in 2 pediatric cardiology centers in 
Khartoum.  
Methodology: It was a prospective cross sectional study. Patients were examined clinically and by 
echocardiography. Serum high sensitivity C-reactive protein (hsCRP) was measured from children with 
Acute RF as well as from healthy age and sex matched controls selected from children attending the 
clinics. Statistical Analysis Used: Mean and standard deviation, P value using Fisher’s exact test. 
Results: Sixty six patients (45% males) were enrolled. Mitral regurgitation (MR) was found in 65 
patients (98%), it was severe in 42 patients (64%), combined with aortic regurgitation (AR) in 27 
patients (41%) and with Mitral stenosis (MS) in 3 patients (4.5%). For patients with carditis, hsCRP 
ranged between 1.10 and 15 mg/l (mean 8.0817, SD 4.47). In the control group it was 0.6-1.3 mg/l 
(mean 0.93 SD 0.23) P<0.0001.Patients with Acute RF had hsCRP mean of 12.35 mg/l (SD 2.11) while 
those with chronic RHD had hsCRP mean of 7.34 mg/l (SD 4.16), P<0.0001.  
Conclusion: RHD is manifested in our patients with severe valve damage dominated by MR and there 
is evidence of an ongoing inflammation during the chronic phase. RHD is manifested in a severe form 
in Sudan. High sensitivity CRP is elevated in acute phase as well as in the chronic phase. 
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 heumatic fever (RF) and Rheumatic 
heart disease (RHD) are the leading 
causes of cardiovascular mortality and 
morbidity in developing countries. 
Prevalence rates in Sudan range from 2-14 per 
100000 1, 2. Clinical and echocardiographic 
(echo) features are not fully delineated in this 
area. RF is a delayed autoimmune response to 
Group A streptococcal  pharyngitis,  and  the  
clinical manifestation of the response and its 
severity in an individual is determined by host 
genetic susceptibility, the virulence of the 
infecting  organism  and  the  conducive 
1.Mutaz Khalifa, MD, Ministry of Health, Khartoum, 
Sudan. 
 2. Sulafa KM Ali, FRCPCH, FACC, Sudan Heart Center 
and University of Khartoum, Faculty of Medicine, 
Department of Pediatrics and Child Health.  
*Correspondent:sulafakhalid2000@yahoo.com 
environment. C-reactive protein (CRP) is a 
protein found in the blood and it is a "marker" 
of inflammation, its presence indicates a 
heightened state of inflammation in the body. 
There is growing evidence that serum CRP is 
elevated in these patients both in acute and 
chronic phases putting them at risk of 
increasing valve damage3.  This study looked at 
the clinical and echo features in relation to the 
serum high sensitivity (hs) CRP.  
 
PATIENTS AND METHODS 
The study was prospective cross sectional study 
carried at 2 pediatric cardiac clinics in 
Khartoum state; the main children’s hospital, at 
the pediatric cardiology department and Sudan 
Heart Center from September 2011 to January 
2012. After an informed consent, all patients 
with Acute RF (ARF) (with carditis), diagnosed 
R
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by the Jone’s Criteria and confirmed by echo, 
were included. Physical examination 
(performed by the first author) and echo study 
(2-dimentional and Doppler performed by the 
second author) were done for each patient. 
Rheumatic MR was diagnosed by the 
characteristic echo features including 
thickening of the leaflet tips, superior 
malcoaptation of the anterior leaflet and 
restricted motion of the posterior leaflet. 
Rheumatic AR was diagnosed by the presence 
of irregular leaflet thickening and lack of 
coaptation4.  High sensitivity C reactive protein 
(hs CRP) was done using ELISA method for 
each patient and from healthy age and sex 
matched controls selected from children 
attending the clinics. Mean and standard 
deviation, P value using Fisher’s exact test 
were calculated.   
 
RESULTS 
Sixty six patients (45% males) were enrolled. 
The age ranged between 9-15 years (mean 
11.3). Fifty eight patients (87.8%) had RHD 
and 8 (12.1%) had ARF with carditis.  57 cases 
(86.3%) were in New York Heart Association 
(NYHA) class I-II whereas 9 cases (13.6%) 
were in class III-IV. Fifty four patients were on 
penicillin prophylaxis, out of them, 31 patients 
had one or more doses missed (57.4%). 
Echocardiographic Findings: 
Table 1 summarizes the echo findings.  
Mitral regurgitation (MR) was found in 65 
patients (98.4%), it was isolated in 35 cases 
(53.8% of cases of MR), combined with aortic 
regurgitation (AR) in 27 cases (41.5%), and 
with mitral stenosis (MS) in 3 cases. AR was 
present in 28 patients (41.4%), it was isolated 
in only 1 patient. (1.5%).Tricuspid 
regurgitation (combined with other lesions) was 
found in 19 cases (28.7%).  
MR was mild in 23 patients (35.3%), and 
severe in 42 (64.4%). AR was mild in 23 
patients (85.1%) and severe in 5 (18.5%) of 
cases of AR. Pulmonary hypertension was 
present in 15 cases (22.7%) and a low ejection 
fraction was found in 7 cases (10.6%).    
 High sensitivity CRP: 
The normal range of hsCRP according to our 
lab is as follows: 
Females (5-18yrs): less than 1.9mg/l 
Males (5-13yrs): less than 1.45 mg/l. 
Males (14-18yrs): less than 2.13mg/l. 
For patients with carditis, hsCRP ranged 
between 1.10 and 15 mg/l (mean 8.0817, SD 
4.47). In the control group it was 0.6-1.3 mg/l 
(mean 0.93 SD 0.23) P<0.0001 (Table 2). 
Patients with ARF had hsCRP mean of 12.35 
mg/l (SD 2.11) while those with chronic RHD 
had hsCRP mean of 7.34 mg/l (SD 4.16), 
P<0.0001 (Table 3). 
Patients with a single valve lesion (33 cases) 
had hsCRP mean of 5.35 mg/l (SD 2.96) and 
those with multiple lesions (33 cases) had a 
mean of 9.2568 mg/l (SD 4.28) P=0.06  
Patients with mild valvular lesions had a mean 
hsCRP of 7.5274 mg/l (SD 4.55) and those with 
severe MR mean of 8.4998 mg/l (SD 4.43), 
P=0.4 (Table 4). 
 
Table 1: Echocardiographic Findings  
Lesion Frequency Percent 
Isolated   MR 
               Mild 








  (all severe MR) 
27 40.9 
MS/MR  3 4.5 
Isolated AR 1 1.5 
Total 66  100.0 
 
DISCUSSION 
The clinical and echo features in this cohort of 
patients showed predominant chronic RHD 
with severe valve damage. The patients 
presented with established valve lesions 
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Table 2: Comparison between Cases and Control Group hsCRP 
Category  N Minimum Maximum Mean Std. Deviation 
Cases 
hsCRP 66 
1.10 15.00 8.0817 4.47459* Valid N 66 
Controls 
hsCRP 10 
0.60 1.30 0.9300 0.23594 
Valid N  10 
* P<0.0001 
 
with possible recurrent episodes. Those who 
had been diagnosed and put on secondary 
prophylaxis are mostly non compliant. In 
addition, multi valve affection was common 
raising concerns about the efficacy of 
secondary prophylaxis in such patients. It is 
obvious that secondary prophylaxis alone is not 
enough to control the devastating sequelae of 
ARF; moreover, RHD control programs in 
Africa proved that combining secondary 
prophylaxis with primary prophylaxis, health 
awareness, surveillance and advocacy is the 
way to achieve a better control5.  
The echo patterns of valve affection in this 
study showed predominance of MR followed 
by combined MR and AR, findings that are 
comparable to those reported in Sudan as well 
as other countries with similar prevalence of 
ARF and RHD. However the lesions in our 
patients tended to be more severe with higher 
frequency of pulmonary hypertension and low 
ejection fraction, probably related to late 
diagnosis and more relapses6,7,8. The 
pathogenesis of rheumatic carditis and 
mechanisms of progressive valve destruction 
are not yet fully understood. 
 
Table 3: Comparison between hsCRP in acute RHD and chronic RHD 
 Type of Carditis N Mean Std. Deviation Std. Error Mean 
Hs CRP Acute 8 12.3500 2.11862 0.74905* 
 Chronic 58 7.3497 4.16711 0.54717 
*P<0.0001 
 
Host genetic susceptibility, the virulence of the 
infecting organism, and the environment which 
is conducive all contributed to the severity of 
cardiac affection. The role of continuing 
inflammation indicated by the high level of 
hsCRP, well as the role of hsCRP as a causative 
factor of valve damage had been recently 
raised9. This study proved that patients in the 
chronic phase continued to have high level of 
hsCRP compared to controls. Those with 
multiple valve affection tended to have higher 
hsCRP levels, though not reaching statistical 
significance. The severity of the lesion did not 
correlate statistically with the level of hsCRP, 
probably  because  many patients   had multiple 
valve affection. 
 
Table 4: Comparison between hs CRP in patients with one valve versus multiple valves lesions  
 
 Valves affected N Mean Std. Deviation Std. Error Mean 
Hs CRP One valve 33 5.3536 2.96140 0.63137 
Multiple valves 33 9.2568* 4.28460 0.64593 
*P<0.06
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We have also observed an ongoing 
inflammation in a study that looked at the level 
of cytokines in patients with RHD which 
revealed a high level of tumor necrosis factor 
alpha10. 
Therefore, hsCRP may be considered as a test 
for monitoring patients with ARF and RHD, 
however, the implications of increased hsCRP 
on treatment needs to be further studied. 
Potential therapeutic options include prolonged 
use of anti inflammatory or immune 
modulating drugs to test their effectiveness in 
controlling the ongoing inflammation.  
In conclusion, RHD is manifested in our 
patients with severe valve damage dominated 
by MR and there is evidence of an ongoing 
inflammation during the chronic phase.  
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